<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title><![CDATA[MetaboloStasis Therapeutics ]]></title>
        <description><![CDATA[MetaboloStasis Therapeutics ]]></description>
        <link>https://thegrid.ai/metabolostasis/</link>
        <generator>The Grid</generator>
        <lastBuildDate>Sun, 20 Dec 2015 00:36:10 GMT</lastBuildDate>
        <atom:link href="https://thegrid.ai/metabolostasis/rss.xml" rel="self" type="application/rss+xml"/>
        <item>
            <title><![CDATA[No title]]></title>
            <description><![CDATA[<img src="http://nebula.wsimg.com/e19a0b60ff7533b34c40cc31661ab077?AccessKeyId=A0CE1EF33ABC5529819D&disposition=0&alloworigin=1">]]></description>
            <link>https://thegrid.ai/metabolostasis/cc16d88b-01a4-4862-979c-7d2a802a5f3d/index.html</link>
            <guid isPermaLink="false">cc16d88b-01a4-4862-979c-7d2a802a5f3d</guid>
            <pubDate>Sun, 20 Dec 2015 00:36:10 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Home]]></title>
            <description><![CDATA[<article><h1>Home</h1><p>METABOLOSTASIS THERAPEUTICS is committed to the development of novel therapeutics for the treatment of rare diseases. Current research focuses on disorders of copper metabolism, an essential micro-nutrient whose deficiency or excess leads to immune dysfunction, heart disease, tumor development as well as dramatic neurodegeneration.</p><img src="https://s3-us-west-2.amazonaws.com/the-grid-img/p/a8ea4e47b7281cfcbd68e34d705b44276f06a0b0.jpg"></article>]]></description>
            <link>http://www.metabolostasis.com/</link>
            <guid isPermaLink="false">b1b15d2d-e553-4a38-9af9-becd167e5ed0</guid>
            <pubDate>Sat, 19 Dec 2015 21:41:26 GMT</pubDate>
        </item>
    </channel>
</rss>